Drug resistance R&D set in South Africa

LifeArc and the University of Cape Town’s Holistic Drug Discovery and Development Centre have partnered to create an institute at the center for studying and combating antimicrobial resistance. Research efforts will focus on multidrug resistant gram-negative bacteria; special emphasis will be on the antibiotic carbapenem and colistin-resistant Acinetobacter baumannii . LifeArc has put more than $6 million into the partnership.